Trial Profile
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Morphine
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms IMPROVE-IR
- Sponsors Pacira Pharmaceuticals
- 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
- 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the World Congress of Enhanced Recovery after Surgery and Perioperative Medicine, Plastic Surgery Research Council (PSRC).
- 26 Feb 2013 Official title amended as reported by ClinicalTrials.gov.